AstraZeneca Names New CEO, Faces More Competition

REPLAY VIDEO
Your next video will start in
Pause
  • Info

  • Comments

Aug. 28 (Bloomberg) -- Bloomberg's Erik Schatzker reports that AstraZeneca named Pascal Soriot as chief executive officer as the company faces increased generic competition. He speaks on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change